Canada markets closed

Legend Biotech Corporation (LEGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
43.74-1.40 (-3.10%)
At close: 04:00PM EDT
43.94 +0.20 (+0.46%)
After hours: 05:34PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
285,143
285,143
117,005
68,826
75,000
Cost of Revenue
144,214
144,214
65,363
0
0
Gross Profit
140,929
140,929
51,642
68,826
75,000
Operating Expenses
Research Development
382,218
382,218
335,648
313,346
232,160
Selling General and Administrative
200,927
200,927
174,048
149,503
72,705
Total Operating Expenses
580,414
580,414
507,262
461,113
301,793
Operating Income or Loss
-439,485
-439,485
-455,620
-392,287
-226,793
Interest Expense
21,794
21,794
10,796
900
195
Total Other Income/Expenses Net
-113,326
-113,326
12,510
-14,980
-80,213
Income Before Tax
-520,118
-520,118
-445,724
-407,196
-308,285
Income Tax Expense
-1,864
-1,864
625
-3,614
-41,912
Income from Continuing Operations
-518,254
-518,254
-446,349
-403,582
-266,373
Net Income
-518,254
-518,254
-446,349
-403,582
-266,373
Net Income available to common shareholders
-518,254
-518,254
-446,349
-403,582
-266,373
Basic EPS
-2.96
-2.94
-2.80
-2.86
-2.26
Diluted EPS
-2.96
-2.94
-2.80
-2.86
-2.26
Basic Average Shares
171,867
176,083
159,042
140,852
118,153
Diluted Average Shares
171,867
176,083
159,042
140,852
118,153